Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$907M |
| 2 |
Apple
AAPL
|
+$260M |
| 3 |
Microsoft
MSFT
|
+$223M |
| 4 |
Amazon
AMZN
|
+$173M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$160M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$471M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$177M |
| 3 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$160M |
| 4 |
Petrobras
PBR
|
+$153M |
| 5 |
Adobe
ADBE
|
+$146M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.79% |
| 2 | Healthcare | 12.41% |
| 3 | Financials | 9.98% |
| 4 | Consumer Discretionary | 9.11% |
| 5 | Communication Services | 6.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
Sotera Health
SHC
$5.13B
| $472K | ﹤0.01% |
+24,095
| New | +$505K |
|
652
Citizens Financial Group
CFG
$31.1B
| $470K | ﹤0.01% |
+13,158
| New | +$520K |
|
653
Vanguard Short-Term Bond ETF
BSV
$44.6B
| $458K | ﹤0.01% |
5,968
+1,239
| +26% | +$95.5K |
|
654
Expedia Group
EXPE
$38.4B
| $453K | ﹤0.01% |
4,777
+1,197
| +33% | +$169K |
|
655
Cognizant
CTSH
$25.1B
| $450K | ﹤0.01% |
6,668
+3,953
| +146% | +$303K |
|
656
J.M. Smucker
SJM
$12.7B
| $447K | ﹤0.01% |
3,491
+1,601
| +85% | +$214K |
|
|
NSA
657
DELISTED
National Storage Affiliates Trust
NSA
| $445K | ﹤0.01% |
8,878
-189
| -2% | -$10.3K |
|
658
British American Tobacco
BTI
$128B
| $442K | ﹤0.01% |
10,293
-1,327
| -11% | -$56.9K |
|
659
Live Nation Entertainment
LYV
$42.8B
| $442K | ﹤0.01% |
5,356
-191
| -3% | -$18.4K |
|
660
KLA
KLAC
$252B
| $440K | ﹤0.01% |
13,770
-8,840
| -39% | -$297K |
|
661
Citigroup
C
$231B
| $438K | ﹤0.01% |
9,514
+1,595
| +20% | +$79.8K |
|
662
CGI
GIB
$15B
| $430K | ﹤0.01% |
+5,392
| New | +$435K |
|
663
STMicroelectronics
STM
$47.1B
| $427K | ﹤0.01% |
13,583
+423
| +3% | +$15.8K |
|
664
Fastenal
FAST
$57.4B
| $426K | ﹤0.01% |
+17,066
| New | +$460K |
|
665
Palo Alto Networks
PANW
$296B
| $426K | ﹤0.01% |
5,178
+84
| +2% | +$7.45K |
|
|
SPPI
666
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $425K | ﹤0.01% |
545,198
| – | – |
|
667
Genuine Parts
GPC
$18.1B
| $424K | ﹤0.01% |
3,184
-57
| -2% | -$7.59K |
|
668
KeyCorp
KEY
$24.8B
| $424K | ﹤0.01% |
+24,599
| New | +$476K |
|
669
Exelon
EXC
$47.1B
| $423K | ﹤0.01% |
9,342
+165
| +2% | +$7.76K |
|
670
Dow Inc
DOW
$21.4B
| $422K | ﹤0.01% |
8,180
+378
| +5% | +$24.2K |
|
|
CTRA
671
DELISTED
Coterra Energy
CTRA
| $418K | ﹤0.01% |
16,219
+3,574
| +28% | +$108K |
|
672
Eaton
ETN
$174B
| $418K | ﹤0.01% |
3,320
+283
| +9% | +$39.6K |
|
673
iShares US Broker-Dealers & Securities Exchanges ETF
IAI
$1.38B
| $414K | ﹤0.01% |
4,926
+71
| +1% | +$6.39K |
|
674
Vanguard Consumer Discretionary ETF
VCR
$6.3B
| $410K | ﹤0.01% |
1,802
+192
| +12% | +$50.1K |
|
675
UBS Group
UBS
$176B
| $404K | ﹤0.01% |
24,907
-293
| -1% | -$5.14K |
|
Similar funds
Ken Fisher's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Fisher held 1,196 positions worth $141B, down 17% from $169B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Ken Fisher's Q2 2022 filing shows 110 new, 483 increased, 318 reduced and 131 closed positions. Its largest new stake was Woodside Energy: 6,156,348 shares worth $133M. The largest sale was Eli Lilly, an estimated $471M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.
- Ken Fisher's largest Q2 2022 buy was Woodside Energy: 6,156,348 shares worth $133M.
- Ken Fisher added most to Johnson & Johnson in Q2 2022, an estimated $907M increase.
- Ken Fisher's biggest Q2 2022 reduction was Eli Lilly, cutting an estimated $471M.
- Ken Fisher fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $160M.
- Ken Fisher's ten largest holdings make up 30% of its $141B portfolio in Q2 2022.
- Ken Fisher opened 110 new positions and closed 131 in Q2 2022.
- Ken Fisher's portfolio value fell 17% quarter-over-quarter to $141B.
Based on Fisher Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.